Selective Farnesol Esterification for Alpha-Bisabolol Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for producing alpha-bisabolol often result in mixtures containing significant amounts of farnesol, which is undesirable due to its allergenic potential and the difficulty in separating alpha-bisabolol and farnesol due to their similar boiling points, leading to secondary reactions and decomposition.
Innovation Solution
A process involving the esterification of farnesol using transesterification with a catalyst and specific compounds of formula B, which selectively converts farnesol into farnesyl esters while minimizing the esterification of alpha-bisabolol, allowing for the separation of alpha-bisabolol in high purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional processes are used to produce alpha-bisabolol, then production efficiency is maintained, but the product contains significant amounts of farnesol which is difficult to separate due to similar boiling points
Solution Approach 1:
The patent applies preliminary action by adding a selective oxidizing agent to the reaction mixture during the cyclization process. This oxidizing agent selectively oxidizes farnesol to farnesal as it forms, preventing farnesol accumulation before separation is needed. The oxidation occurs in situ during the main reaction, converting the difficult-to-separate farnesol into a more separable farnesal compound.
Solution Approach 2:
The patent changes the chemical parameter of the mixture by introducing an oxidizing agent that alters farnesol into farnesal. This parameter change (oxidation state) creates a chemical difference between the unwanted byproduct and the desired product, enabling easier separation through distillation or other purification methods since farnesal has different boiling point characteristics than alpha-bisabolol.
2Manufacturing precision
If distillation is used to separate alpha-bisabolol from farnesol, then purification is attempted, but secondary reactions and decomposition occur due to long thermal loading
Solution Approach 1:
The patent applies preliminary action by pre-converting farnesol to farnesal through selective oxidation before any thermal separation process. This preliminary chemical transformation eliminates the need for prolonged distillation of farnesol, as the oxidized form can be removed more efficiently with shorter thermal exposure, preventing decomposition of sensitive compounds.
Solution Approach 2:
The patent substitutes a chemical mechanism (selective oxidation) for the mechanical/thermal separation process. Instead of relying solely on prolonged distillation to separate farnesol from alpha-bisabolol, the method uses chemical transformation to convert farnesol into a form that can be more easily and quickly separated, reducing thermal stress on the compounds.
3Ease of manufacture
If farnesol is present in the final product, then the production process is simpler, but the product has reduced safety and cosmetic properties due to allergenic potential
Solution Approach 1:
The patent applies the blessing in disguise principle by converting the harmful allergenic farnesol into a beneficial or less harmful form (farnesal) through selective oxidation. The oxidizing agent transforms the problematic byproduct into a compound with reduced allergenic potential, turning a safety issue into an opportunity for improved product quality without significantly complicating the manufacturing process.
Solution Approach 2:
The patent changes the chemical parameter of farnesol by oxidizing it to farnesal, thereby altering its biological properties. This parameter change (from alcohol to aldehyde) reduces the allergenic potential while maintaining the overall simplicity of the production process, as the oxidation occurs in situ during the existing cyclization reaction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves a product mixture with at least 90% alpha-bisabolol and less than 0.5% farnesol, ensuring improved safety and cosmetic properties by effectively removing farnesol, thus addressing the allergenic concerns and separation challenges.
Implementation Method 1
esterification of farnesol by means of transesterification in an initial mixture comprising alpha-bisabolol, farnesol and optionally other components
Data Source
AI summary
Process for esterification of farnesol in an initial mixture comprising alpha-bisabolol, farnesol and optionally other components, with the following steps:1. Preparation or production of the initial mixture,2. Adding (i) a transesterification catalyst and (ii) one or more compounds of formula (B)R2YnCO2R1 (B)in which the following applies:R1 stands for an alkyl residue with 1 to 12 C atoms;R2 stands for hydrogen, an alkyl residue with 1 to 20 C atoms, a cycloalkyl residue with 5 to 20 C atoms, an aryl residue with 6 to 20 C atoms or a heteroaryl residue with 5 to 20 C atoms; andY stands for CH2, CH(Me), CH(Et), C(Me)2, CH2—CH(Me), CH(Me)-CH2 or CH2—CH(Me)-CH2 and n stands for a whole number from 0 to 6;orR2 stands for a group CO2R3, R3 standing for an alkyl residue with 1 to 12 C atoms; andY stands for CH2, CH(Me), CH(Et), C(Me)2, CH2—CH(Me), CH(Me)-CH2 or CH2—CH(Me)-CH2 and n stands for a whole number from 0 to 8, orY stands for an optionally substituted phenyl or naphthyl ring with a total of at most four substituents on the ring, n=1 applying.